IE882411L - Novel crystalline 7-£2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido|-3-vinyl- 3-cephem-4-carboxylic acid (syn isomer) - Google Patents

Novel crystalline 7-£2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido|-3-vinyl- 3-cephem-4-carboxylic acid (syn isomer)

Info

Publication number
IE882411L
IE882411L IE882411A IE241188A IE882411L IE 882411 L IE882411 L IE 882411L IE 882411 A IE882411 A IE 882411A IE 241188 A IE241188 A IE 241188A IE 882411 L IE882411 L IE 882411L
Authority
IE
Ireland
Prior art keywords
hydroxyiminoacetamido
aminothiazol
cephem
vinyl
syn isomer
Prior art date
Application number
IE882411A
Other versions
IE67348B1 (en
Inventor
Takao Takaya
Fumiyuki Shirai
Hitoshi Nakamura
Yasunobu Inabo
Original Assignee
Nativelle Sa Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16519432&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE882411(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nativelle Sa Ets filed Critical Nativelle Sa Ets
Publication of IE882411L publication Critical patent/IE882411L/en
Publication of IE67348B1 publication Critical patent/IE67348B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Crystalline 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4 -carboxyli c acid (syn isomer) which is obtainable by acidifying a solution containing 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido-3-vinyl-3-cephem-4- carboxylic acid (syn isomer) at room temperature or under warming. Such crystalline compound shows a characteristic X-ray diffraction pattern. The invention comprises also processes for preparing such crystalline compound and pharmaceutical compositions containing it as active ingredient.
IE241188A 1987-08-19 1988-08-05 Novel crystalline 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) IE67348B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20619987 1987-08-19

Publications (2)

Publication Number Publication Date
IE882411L true IE882411L (en) 1989-02-19
IE67348B1 IE67348B1 (en) 1996-03-20

Family

ID=16519432

Family Applications (1)

Application Number Title Priority Date Filing Date
IE241188A IE67348B1 (en) 1987-08-19 1988-08-05 Novel crystalline 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid (syn isomer)

Country Status (11)

Country Link
US (1) US4935507A (en)
EP (1) EP0304019B1 (en)
KR (1) KR970008126B1 (en)
AT (1) ATE123221T1 (en)
AU (1) AU617347B2 (en)
CA (1) CA1297096C (en)
DE (1) DE3853901T2 (en)
ES (1) ES2072856T3 (en)
HK (1) HK18496A (en)
IE (1) IE67348B1 (en)
ZA (1) ZA885709B (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405283B (en) * 1997-04-04 1999-06-25 Biochemie Gmbh NEW CRYSTALLINE 7- (Z) - (2- (2-AMINOTHIAZOL-4-YL) -2-HYDROXYIMINOACETAMIDO) -3-VINYL-3-CEPHEM-4- CARBONIC ACID DICYCLOHEXYLAMMONIUM SALTS AND METHODS FOR THE PRODUCTION THEREOF
US6888124B1 (en) 1999-03-24 2005-05-03 Shell Oil Company Method to monitor internal parameters of electrical motor systems
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
KR20040008158A (en) * 2001-04-17 2004-01-28 랜박시 래보러터리스 리미티드 Process for the preparation of cefpodoxime acid
KR100451672B1 (en) 2001-06-05 2004-10-08 한미약품 주식회사 Crystalline acid salts of cefdinir, process for their preparation and process for the preparation of cefdinir using same
KR20030018536A (en) * 2001-08-30 2003-03-06 임득수 The methode of surface treatment for glass products
AU2002347539A1 (en) * 2001-12-13 2003-06-23 Ranbaxy Laboratories Limited Crystalline cefdinir potassium dihydrate
US7297800B2 (en) * 2001-12-27 2007-11-20 Ajinomoto Co., Inc. Process of producing glutamate derivatives
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
ITMI20020913A0 (en) * 2002-04-29 2002-04-29 Acs Dobfar Spa NEW CRYSTALLINE FORM OF CEFDINIR
US6800756B2 (en) * 2002-05-03 2004-10-05 Orchid Chemicals And Pharmaceuticals, Ltd. Method for the preparation of ceftiofur sodium and its intermediates
EP1554289B1 (en) * 2002-08-13 2011-03-09 Sandoz Ag A cefdinir intermediate
RU2307871C2 (en) 2002-08-26 2007-10-10 Адзиномото Ко., Инк. New aldolase and method for production of substituted alpha-ketoacids
WO2004046154A1 (en) * 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
EP2557160A3 (en) 2002-12-09 2013-03-27 Ajinomoto Co., Inc. Mutated D-aminotransferase and method for producing optically active glutamic acid derivatives using the same
ITMI20022724A1 (en) 2002-12-20 2004-06-21 Antibioticos Spa CRYSTALLINE SALTS OF CEFDINIR.
AU2004206821C1 (en) 2003-01-14 2009-10-01 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
EP1609793A4 (en) * 2003-03-24 2008-06-25 Sandoz Ag Novel crystal of 7- 2-(2-aminothiazole-4-yl)-2-hydroxyiminoa cetamido-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US7098329B2 (en) * 2003-06-19 2006-08-29 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of a cephalosporin antibiotic
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050059819A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20080139528A1 (en) * 2003-12-10 2008-06-12 Pujara Chetan P Cefdinir oral suspension
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
WO2006059753A1 (en) * 2004-11-30 2006-06-08 Astellas Pharma Inc. Novel oral pharmaceutical suspension of cefdinir crystal
GB2421024A (en) * 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
WO2006117794A1 (en) * 2005-05-02 2006-11-09 Hetero Drugs Limited A novel crystalline form of cefdinir
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (en) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc Unitary pharmaceutical dosage form
KR100912214B1 (en) * 2005-10-31 2009-08-14 테바 파마슈티컬 인더스트리즈 리미티드 Crystalline form of cefdinir cesium salt
US20070244315A1 (en) * 2005-10-31 2007-10-18 Kansal Vinod K Process for the preparation of cefdinir
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
ITMI20071628A1 (en) 2007-08-06 2007-11-05 Acs Dobfar Spa SYNTHESIS OF 3-ALCHENYLCEPHALOSPORINES AND NEW INTERMEDIATE USEFUL RELATED
CN101481383B (en) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 Cefdinir acid type double salt compound and preparation
TR201000686A1 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Water-soluble cefdinir and clavulanic acid formulations for the treatment of bacterial infections.
JP6151257B2 (en) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． Treatment of pulmonary infections
CN102643293A (en) * 2012-03-30 2012-08-22 石药集团中诺药业（石家庄）有限公司 Cefdinir ternary complex and method for preparing cefdinir by using same
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
CN103012433B (en) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 Preparation method of cefdinir crystal form B
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3100732A1 (en) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622933B (en) * 2013-12-19 2015-04-08 石家庄市华新药业有限责任公司 Cefdinir capsule and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8323034D0 (en) * 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds

Also Published As

Publication number Publication date
DE3853901T2 (en) 1995-10-12
EP0304019A2 (en) 1989-02-22
AU2099888A (en) 1989-02-23
ATE123221T1 (en) 1995-06-15
EP0304019B1 (en) 1995-05-31
IE67348B1 (en) 1996-03-20
CA1297096C (en) 1992-03-10
KR890003778A (en) 1989-04-18
DE3853901D1 (en) 1995-07-06
EP0304019A3 (en) 1990-12-27
KR970008126B1 (en) 1997-05-21
ZA885709B (en) 1989-04-26
US4935507A (en) 1990-06-19
AU617347B2 (en) 1991-11-28
ES2072856T3 (en) 1995-08-01
HK18496A (en) 1996-02-09

Similar Documents

Publication Publication Date Title
IE882411L (en) Novel crystalline 7-£2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido|-3-vinyl- 3-cephem-4-carboxylic acid (syn isomer)
DK0513543T3 (en) Amidinophenylalanine derivatives, processes for their preparation, their use and anticoagulants containing them
NO173015C (en) ANALOGUE PROCEDURE FOR PREPARATION OF PYRIDO (1,2-A) PYRIMIDIN-3-PIPERIDINYL-1,2-BENZISOXAZOLS
HU901627D0 (en) Process for the preparation of novel n-(3-hydroxy-4-piperidinyl)-dihydrobenzofurane-,-dihydro-2h-benzopyrane- and -dihydro-benzo-dioxy-carboxamide derivatives and pharmaceutical compositions containing them
HUT61303A (en) Process for producing compounds comprising 1,6-naphthyridine ring system and pharmaceutical compositions comprising same as active ingredient
HU9600452D0 (en) Compounds avaiable for preparation of isoxazole-derivatives
IL77197A (en) Benzoxazol-and benzothiazolamine derivatives,their preparation and pharmaceutical compositions containing them
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
IL98464A0 (en) Dibenzoylalkylcyano-hydrazines,their preparation and their use as pesticides
AU4356693A (en) Novel crystal of monohydrate of heterocyclic bis(phosphonic acid) derivative
HUT43939A (en) Herbicide comprising substituted semicarbazone or thiosemicarbazone derivatives as active substance and process for preparing the active substance
DK513080A (en) 6- (1-HYDROXYETHYL) -2- (2-AMINOETHYLTHIO) -1,1-DISUBSTITUTED 1-CARBADETHYAPEN-2-EM-3-CARBOXYLIC ACID AND PROCEDURE FOR PREPARING THEREOF
MX9300875A (en) PROCEDURE FOR THE PREPARATION OF AZABICICLIC COMPOUNDS.
ES2053946T3 (en) A PROCEDURE FOR THE PREPARATION OF TETRAHIDROIMIDAZO (1,4) BENZODIAZEPIN-2-ONAS.
DK0402806T3 (en) Crystalline cephemic acid addition salts and process for their preparation
NO171502C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE THIADIAZOLYLACETAMIDE CEFEM DERIVATIVES
PT91613A (en) PROCESS FOR THE PREPARATION OF ANTIHYPERTENSIVE 3-PIPERIDINYL-INDAZOLE DERIVATIVES
PT73948B (en) Process for the preparation of biologically active heterobicyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
FR2612173B1 (en) PROCESS FOR THE PREPARATION OF HIGH PURITY MANGANESE COMPOUNDS
HUT53654A (en) Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds
AR242030A1 (en) A procedure for the preparation of the formula 2 crystalline from ranitidine hydrochloride.

Legal Events

Date Code Title Description
SPCF Request for grant of supplementary protection certificate

Free format text: SPC032/2000, 20001221

SPCW Supplementary protection certificate withdrawn

Spc suppl protection certif: SPC032/2000

Filing date: 20001221

MK9A Patent expired